Austria to confine people who are not vaccinated against coronavirus | Coronavirus

The Austrian government officially announced that from the first minute of this Monday, November 15, there will be new social restrictions that will exclusively affect people who have not been vaccinated or overcome the coronavirus. The information was delivered this Sunday (11/14/2021) by the federal chancellor, the conservative Alexander Schallenberg.

“The situation is serious. The fourth wave (of the pandemic) affects us fully. This is due to the delta variant (of the virus), but also to the low vaccination rate,” the federal chancellor, the conservative, told the press. Alexander Schallenberg. “We do not take this measure lightly, unfortunately it is necessary,” he added.

Only 65 percent of the Austrian population susceptible to being inoculated has received any of the four vaccines (BioNTech, Moderna, AstraZeneca and Janssen) approved in Europe to combat SARS-CoV-2, which makes this country one of the those with the lowest vaccination rate in Western Europe, compared to almost 80 percent in Spain and 75 percent in France.

Alexander Schallenberg at the conference where he announced the news.

–

High incidence among unvaccinated

This measure, which must be approved by Parliament -which is considered to be a mere procedure, due to prior agreement-, implies that as of Monday those who have refused to be vaccinated and have not overcome COVID-19 will only be able to leave their homes to go to work, study or buy basic necessities, in addition to going to the doctor, going for a walk or, of course, going to be vaccinated.

However, they will be totally prohibited from shopping in non-essential stores, going to restaurants, bars, gyms and cultural and sporting events, among others. This will affect everyone over 12 years of age and there will be strict control, authorities warned. The government will evaluate the results of these restrictions within ten days, said Health Minister Wolfgang Mückstein, calling on those reluctant to get vaccinated to do so as soon as possible.

Chancellor Schallenberg specified that the incidence of infections among unvaccinated people is in Austria at about 1,700 cases per 100,000 inhabitants, with a strong upward trend, while among vaccinated it is 383 cases, with a downward trend. The fines for not complying with the norm will range from 500 euros for individuals to 3,600 for companies.

DZC (EFE, AFP)

coronavirus" data-date="20210303" data-firstcategory="19990007">

–

The vaccines that promise to defeat the coronavirus

Sputnik V, Instituto Gamaleya

The “Russian vaccine” aroused initial mistrust, but it has established itself as an option for a score of countries, including Argentina, Bolivia and Venezuela. The doubts arose due to its rapid approval, in August 2020, without having finished the tests. However, subsequent studies give a high efficacy to this preparation, which uses adenoviral vectors to elicit immunity.

–

–

The vaccines that promise to defeat the coronavirus

BNT162b2, BioNTech/Pfizer

The vaccine from the German firm BioNTech uses a previously unpublished technology: lipid-covered mRNA. Simply explained, the vaccine “mimics” the form of SARS-CoV-2, eliciting the body’s response. In trials it showed high efficacy, which has been replicated in real conditions. The Pfizer firm acts in the alliance as a manufacturing partner. It is used in a score of countries.

–

–

The vaccines that promise to defeat the coronavirus

mRNA-1273, Modern

The vaccine developed by the National Institute of Allergy and Infectious Diseases, the Advanced Biomedical Research and Development Authority (BARDA), and the Moderna firm uses technology similar to BioNTech’s. In trials it showed an efficacy close to 95 percent. Unlike BioNTech, this formula can be stored at -20 degrees. It is used in the US and the European Union.

–

–

The vaccines that promise to defeat the coronavirus

AZD1222, Oxford-AstraZeneca

This vaccine developed by British and Swedish experts uses a modified chimpanzee adenovirus as a vector. The trials took place in the UK, Brazil, South Africa, Japan and India, and were interrupted a couple of times by suspicious deaths. However, its safety and efficacy ranging from 60 to 90 percent have been confirmed. It is used in Brazil, the EU and the UK.

–

–

The vaccines that promise to defeat the coronavirus

Ad5-nCoV, Cansino Biologics

This Chinese firm’s vaccine uses the common cold adenovirus to introduce an inactivated SARS-CoV-2 protein into the human body, eliciting an immune response. It has been used in China to inoculate People’s Army soldiers, and trials were carried out in Russia, Pakistan, Mexico, Chile and Argentina. It is currently used in Mexico, Malaysia, and Indonesia. Use only one dose.

–

–

The vaccines that promise to defeat the coronavirus

CoronaVac, Sinovac Biotech

Like many vaccines that use inactivated viruses, this formula uses SARS-CoV-2 particles obtained in cultures and inactivated before being injected into the body. The presence of these viruses triggers the immune reaction and prevents the disease from developing. Tested in Brazil, Indonesia, Chile and Turkey, it shows an effectiveness of over 60 percent.

–

–

The vaccines that promise to defeat the coronavirus

BBV152, Bharat Biotech

Also with inactivated viruses, this vaccine developed by Bharat and the Indian Council for Medical Research is known as Covaxin, and has shown 81 percent efficacy in clinical trials. At the time, it sparked controversy for having been inoculated in medical workers when the formula was still in phase I clinical trials. India is now seeking approval in other markets.

–

–

The vaccines that promise to defeat the coronavirus

BBIBP-CorV, Sinopharm

With trials in Argentina, Peru, the United Arab Emirates and other states, this Chinese inactivated virus vaccine has already been approved in Middle Eastern countries. According to studies, it would be 86 percent effective. Sinopharm is in the eye of controversy in Peru for having sent “courtesy vaccines” for politicians and for having donated thousands of dollars to the government.

–

–

The vaccines that promise to defeat the coronavirus

Ad26.COV2.S, Johnson & Johnson

Along with CanSino’s, it is the only single-dose vaccine to date. It is developed by the Belgian firm Janssen Pharmaceutica, a subsidiary of the American Johnson & Johnson. It can be stored in a normal refrigerator and has been shown to be more than 66 percent efficient. It uses a non-replicative viral vector derived from human adenovirus A26.

Author: Diego Zúñiga

–